公开(公告)号：US20190275241A1

公开(公告)日：2019-09-12

申请号：US16297408

申请日：2019-03-08

Applicant: AMGEN INC.

Inventor： Lawrence S. Ring ,  Tohid Pirbodaghi ,  Samin Akbari ,  Daniel Eduardo Groszmann ,  Mehran Mojarrad ,  Mark Gordon ,  Mikhail Tikh ,  Jimmie L. Ward ,  Scott R. Gibson ,  Sheldon B. Moberg ,  Joshua Tamsky ,  Paul Faucher

IPC: A61M5/168 ,  A61M5/158 ,  A61M39/24

Abstract: A drug delivery device includes a housing defining a shell and an inner volume, a container, a drive mechanism, a needle assembly, a fluid flow connection, and a backflow prevention mechanism. The container has an inner volume to contain a medicament to be administered to a user. The drive mechanism is at least partially disposed within the housing and exerts a force to urge the medicament out the container. The fluid flow connection is coupled to the container and the needle assembly and allows the medicament to flow from the container to the needle assembly to be administered. The backflow prevention mechanism is associated with at least one of the container, the fluid flow connection, or the needle assembly and includes at least one flow restrictor to restrict a fluid from flowing from the needle assembly to the container.

公开(公告)号：US20170103186A1

公开(公告)日：2017-04-13

申请号：US15315954

申请日：2015-06-03

Applicant: AMGEN INC.

Inventor： Adam B. McCullough ,  Ferry Tamtoro ,  Huaying Yang ,  Mark Ka Lai Lee ,  Desheng Yin ,  Scott R. Gibson ,  Donald Busby ,  Peter V. Shultz ,  Keith P. Kogler ,  Basel Hasan Taha ,  Jimmie L. Ward ,  Steven William Badelt

IPC: G06F19/00 ,  A61M5/32 ,  A61M5/20 ,  A61M5/315 ,  G06Q50/00 ,  A61M5/142

CPC classification number: A61M5/20 ,  A61M5/14244 ,  A61M5/14248 ,  A61M5/158 ,  A61M5/24 ,  A61M5/31501 ,  A61M5/31568 ,  A61M5/3202 ,  A61M5/3243 ,  A61M5/3257 ,  A61M5/326 ,  A61M5/5086 ,  A61M2005/3267 ,  A61M2205/3331 ,  A61M2205/3368 ,  A61M2205/3553 ,  A61M2205/3576 ,  A61M2205/50 ,  A61M2205/502 ,  A61M2205/52 ,  A61M2205/581 ,  A61M2205/6009 ,  G06F19/325 ,  G06F19/3418 ,  G06F19/3468 ,  G06Q50/01 ,  G06Q50/22

Abstract: Systems and methods are disclosed herein for supporting a patient's use of a drug delivery device. The patient may be associated with a support group via, for example, a social networking service for the purpose of increasing the likelihood that the patient will comply with a treatment regimen. Based on data representative of a condition and/or operational state of the drug delivery device, it may be determined whether the patient is compliant with the treatment regimen. If the patient is not compliant, the systems and method disclosed herein may transmit a communication to the support group requesting the support group to counsel the patient about the treatment regimen. The counseling may take the form of words of encouragement, coaching, suggestions, reminders, and/or any other communication likely to urge the patient to comply with the treatment regimen.